ROC curve analysis indicated that NFKB1, AHR, PTEN, TREM1, APP, and LYVE1 expression levels were all capable of classifying AD samples and control samples with moderate accuracy (Figures 10C–E, 0.5 < AUC <0.7). This evidence concerns the gene TREM1 and Alzheimer disease.